全文获取类型
收费全文 | 8802篇 |
免费 | 893篇 |
国内免费 | 721篇 |
出版年
2023年 | 89篇 |
2022年 | 242篇 |
2021年 | 424篇 |
2020年 | 290篇 |
2019年 | 362篇 |
2018年 | 342篇 |
2017年 | 257篇 |
2016年 | 353篇 |
2015年 | 534篇 |
2014年 | 604篇 |
2013年 | 654篇 |
2012年 | 733篇 |
2011年 | 759篇 |
2010年 | 483篇 |
2009年 | 419篇 |
2008年 | 542篇 |
2007年 | 442篇 |
2006年 | 408篇 |
2005年 | 372篇 |
2004年 | 332篇 |
2003年 | 320篇 |
2002年 | 285篇 |
2001年 | 74篇 |
2000年 | 73篇 |
1999年 | 60篇 |
1998年 | 76篇 |
1997年 | 46篇 |
1996年 | 61篇 |
1995年 | 35篇 |
1994年 | 64篇 |
1993年 | 29篇 |
1992年 | 44篇 |
1991年 | 37篇 |
1990年 | 33篇 |
1989年 | 38篇 |
1988年 | 30篇 |
1987年 | 22篇 |
1986年 | 28篇 |
1985年 | 38篇 |
1984年 | 23篇 |
1983年 | 23篇 |
1982年 | 31篇 |
1981年 | 28篇 |
1980年 | 22篇 |
1978年 | 21篇 |
1977年 | 16篇 |
1976年 | 25篇 |
1975年 | 16篇 |
1974年 | 21篇 |
1973年 | 15篇 |
排序方式: 共有10000条查询结果,搜索用时 203 毫秒
141.
142.
143.
144.
145.
成纤维细胞生长因子5(fibroblast growth factor 5,FGF5)是成纤维细胞生长因子家族(FGFs)的成员之一,在哺乳动物毛囊,神经系统,睾丸等多个部位及胚胎发育过程中均有表达.研究发现,FGF5具有广泛的生物学活性,如作为毛发生长重要的调节因子其编码基因突变将导致毛发异常生长,作为丝裂原在干细胞增殖,血管生成和肢体肌发育等方面发挥重要作用,以及在高血压,肿瘤等方面具有重要的生物学功能.目前,FGF5在多种疾病中的功能和作用机制尚需进一步深入研究,但其在毛发生长,干细胞增殖及在心血管疾病等方面的生物学作用具有重大的意义和临床应用价值.总结了近些年FGF5的研究进展,系统阐述了FGF5在毛发生长,干细胞增殖分化,心血管疾病及癌症等方面的相关作用机制,为进一步深入研究FGF5在疾病治疗中的作用和开发利用提供参考. 相似文献
146.
Jun Wang Shaojun Yu Guofeng Chen Muxing Kang Xiaoli Jin Yi Huang Lele Lin Dan Wu Lie Wang Jian Chen 《Journal of cellular and molecular medicine》2020,24(15):8491-8504
Colorectal cancer (CRC) is one of the most commonly diagnosed cancers with an estimated 1.8 million new cases worldwide and associated with high mortality rates of 881 000 CRC‐related deaths in 2018. Screening programs and new therapies have only marginally improved the survival of CRC patients. Immune‐related genes (IRGs) have attracted attention in recent years as therapeutic targets. The aim of this study was to identify an immune‐related prognostic signature for CRC. To this end, we combined gene expression and clinical data from the CRC data sets of The Cancer Genome Atlas (TCGA) into an integrated immune landscape profile. We identified a total of 476 IRGs that were differentially expressed in CRC vs normal tissues, of which 18 were survival related according to univariate Cox analysis. Stepwise multivariate Cox proportional hazards analysis established an immune‐related prognostic signature consisting of SLC10A2, FGF2, CCL28, NDRG1, ESM1, UCN, UTS2 and TRDC. The predictive ability of this signature for 3‐ and 5‐year overall survival was determined using receiver operating characteristics (ROC), and the respective areas under the curve (AUC) were 79.2% and 76.6%. The signature showed moderate predictive accuracy in the validation and GSE38832 data sets as well. Furthermore, the 8‐IRG signature correlated significantly with tumour stage, invasion, lymph node metastasis and distant metastasis by univariate Cox analysis, and was established an independent prognostic factor by multivariate Cox regression analysis for CRC. Gene set enrichment analysis (GSEA) revealed a relationship between the IRG prognostic signature and various biological pathways. Focal adhesions and ECM‐receptor interactions were positively correlated with the risk scores, while cytosolic DNA sensing and metabolism‐related pathways were negatively correlated. Finally, the bioinformatics results were validated by real‐time RT?qPCR. In conclusion, we identified and validated a novel, immune‐related prognostic signature for patients with CRC, and this signature reflects the dysregulated tumour immune microenvironment and has a potential for better CRC patient management. 相似文献
147.
Da Wo Jinxiao Chen Qiongyu Li En Ma Hongwei Yan Jun Peng Weidong Zhu Yong Fang Dan‐ni Ren 《Journal of cellular and molecular medicine》2020,24(16):9466-9471
Vascular endothelial growth factor (VEGF) is a well‐known angiogenic factor, however its ability in promoting therapeutic angiogenesis following myocardial infarction (MI) is limited. Here, we aimed to investigate whether dual treatment with insulin‐like growth factor binding protein‐4 (IGFBP‐4), an agent that protects against early oxidative damage, can be effective in enhancing the therapeutic effect of VEGF following MI. Combined treatment with IGFBP‐4 enhanced VEGF‐induced angiogenesis and prevented cell damage via enhancing the expression of a key angiogenic factor angiopoietin‐1. Dual treatment with the two agents synergistically decreased cardiac fibrosis markers collagen‐I and collagen‐III following MI. Importantly, while the protective action of IGFBP‐4 occurs at an early stage of ischemic injury, the action of VEGF occurs at a later stage, at the onset angiogenesis. Our findings demonstrate that VEGF treatment alone is often not enough to protect against oxidative stress and promote post‐ischemic angiogenesis, whereas the combined treatment with IGFBP4 and VEGF can utilize the dual roles of these agents to effectively protect against ischemic and oxidative injury, and promote angiogenesis. These findings provide important insights into the roles of these agents in the clinical setting, and suggest new strategies in the treatment of ischemic heart disease. 相似文献
148.
Lin Yan Bei Cai Yi Li MinJin Wang YunFei An Rong Deng DongDong Li LiChun Wang Huan Xu XueDan Gao LanLan Wang 《Journal of cellular and molecular medicine》2020,24(24):14270
Recent studies have demonstrated a marked decrease in peripheral lymphocyte levels in patients with coronavirus disease 2019 (COVID‐19) caused by severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2). Few studies have focused on the changes of NK, T‐ and B‐cell subsets, inflammatory cytokines and virus‐specific antibodies in patients with moderate COVID‐19. A total of 11 RT‐PCR‐confirmed convalescent patients with COVID‐19 and 11 patients with non‐SARS‐CoV‐2 pneumonia (control patients) were enrolled in this study. NK, CD8+ T, CD4+ T, Tfh‐like and B‐cell subsets were analysed using flow cytometry. Cytokines and SARS‐CoV‐2‐specific antibodies were analysed using an electrochemiluminescence immunoassay. NK cell counts were significantly higher in patients with COVID‐19 than in control patients (P = 0.017). Effector memory CD8+ T‐cell counts significantly increased in patients with COVID‐19 during a convalescent period of 1 week (P = 0.041). TIM‐3+ Tfh‐like cell and CD226+ Tfh‐like cell counts significantly increased (P = 0.027) and decreased (P = 0.022), respectively, during the same period. Moreover, ICOS+ Tfh‐like cell counts tended to decrease (P = 0.074). No abnormal increase in cytokine levels was observed. The high expression of NK cells is important in innate immune response against SARS‐CoV‐2. The increase in effector memory CD8+ T‐cell counts, the up‐regulation of inhibitory molecules and the down‐regulation of active molecules on CD4+ T cells and Tfh‐like cells in patients with COVID‐19 would benefit the maintenance of balanced cellular and humoural immune responses, may prevent the development of severe cases and contribute to the recovery of patients with COVID‐19. 相似文献
149.
Jierong Luo Dan Yan Sisi Li Shiming Liu Fei Zeng Chi Wai Cheung Hong Liu Michael G. Irwin Huansen Huang Zhengyuan Xia 《Journal of cellular and molecular medicine》2020,24(2):1760-1773
Allopurinol (ALP) attenuates oxidative stress and diabetic cardiomyopathy (DCM), but the mechanism is unclear. Activation of nuclear factor erythroid 2‐related factor 2 (Nrf2) following the disassociation with its repressor Keap1 under oxidative stress can maintain inner redox homeostasis and attenuate DCM with concomitant attenuation of autophagy. We postulated that ALP treatment may activate Nrf2 to mitigate autophagy over‐activation and consequently attenuate DCM. Streptozotocin‐induced type 1 diabetic rats were untreated or treated with ALP (100 mg/kg/d) for 4 weeks and terminated after heart function measurements by echocardiography and pressure‐volume conductance system. Cardiomyocyte H9C2 cells infected with Nrf2 siRNA or not were incubated with high glucose (HG, 25 mmol/L) concomitantly with ALP treatment. Cell viability, lactate dehydrogenase, 15‐F2t‐Isoprostane and superoxide dismutase (SOD) were measured with colorimetric enzyme‐linked immunosorbent assays. ROS, apoptosis, was assessed by dihydroethidium staining and TUNEL, respectively. The Western blot and qRT‐PCR were used to assess protein and mRNA variations. Diabetic rats showed significant reductions in heart rate (HR), left ventricular eject fraction (LVEF), stroke work (SW) and cardiac output (CO), left ventricular end‐systolic volume (LVVs) as compared to non‐diabetic control and ALP improved or normalized HR, LVEF, SW, CO and LVVs in diabetic rats (all P < .05). Hearts of diabetic rats displayed excessive oxidative stress manifested as increased levels of 15‐F2t‐Isoprostane and superoxide anion production, increased apoptotic cell death and cardiomyocytes autophagy that were concomitant with reduced expressions of Nrf2, heme oxygenase‐1 (HO‐1) and Keap1. ALP reverted all the above‐mentioned diabetes‐induced biochemical changes except that it did not affect the levels of Keap1. In vitro, ALP increased Nrf2 and reduced the hyperglycaemia‐induced increases of H9C2 cardiomyocyte hypertrophy, oxidative stress, apoptosis and autophagy, and enhanced cellular viability. Nrf2 gene silence cancelled these protective effects of ALP in H9C2 cells. Activation of Nrf2 subsequent to the suppression of Keap1 and the mitigation of autophagy over‐activation may represent major mechanisms whereby ALP attenuates DCM. 相似文献